The company announced its collaboration with the American Academy of Dermatology on, “Pathways: Inclusivity in Dermatology,” to increase the number of practicing dermatologists in the Black, Latino, and Indigenous communities in medicine over the next 5 years.
Klint Peebles, MD, FAAD, breaks down the core terminology for LGBTQ/SGD individuals so all patients can feel understood when entering the exam room.
In a presentation at the recent AAD annual meeting, Diane M. Thiboutot, MD, discusses the potential risks of antibiotic resistance in acne management.
What’s new in body skin care? According to Neil Sadick, MD, FACP, FAACS, FACph, FAAD, all fingers point to these methods.
In his presentation at the recent AAD, Neil Sadick, MD, FACP, FAACS, FACph, FAAD, highlighted new cosmeceutical concepts for the body, including the whole-body rejuvenation program and AM/PM approach.
Christopher Bunick, MD, PhD, offered pointers on how to address the physical and mental aspects of this complex disease in this exclusive interview in conjunction with the American Academy of Dermatology 2022 Annual Meeting.
In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.
Social media can be a great way to expand exposure for a practice or physician; however, there are many dos-and-don’ts to understand when signing up for a social platform.
Once synonymous with puberty, acne is a growing concern for adults—particularly for women—from the 20s to well into their 40s. Christopher Bunick, MD, PhD delved into treatment options for this increasing patient population at the American Academy of Dermatology 2022 Annual Meeting.
In this video interview, Peter A. Lio, MD, FAAD , discusses his presentation about pain-free dermatology at the 2022 American Academy of Dermatology annual meeting. We talk strategies, benefits, and more.
New data shows complete skin clearance using bimekizumab in moderate to severe plaque psoriasis open-label extension study.
Vitiligo is challenging to treat; fortunately, continued research has led to improvements and refinements in options, giving much-needed hope to patients with this skin condition.
Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.
Experts detailed current evidence-based treatment guidelines for Merkel cell carcinoma at the 2022 American Academy of Dermatology (AAD)’s Annual meeting held March 25 to 29, 2022, in Boston, Massachusetts.
In this video interview, Adam J. Friedman, MD, FAAD, gives the highlights from his presentation at the 2022 American Academy of Dermatology annual meeting about dietary triggers in acne, providing evidence, and discussing how the idea came to be.
An expert debunks the myths surrounding sun-related factors associated with melanoma in a presentation at the 2022 American Academy of Dermatology Annual Meeting.
Anne M Chapas, MD, FAAD, discusses what to do when cosmetic procedures go wrong during a presentation at the AAD 2022 annual meeting.
Experts explored out-of-the-box solutions for treating challenging skin and hair disorders at the American Academy of Dermatology (AAD)’s 2022 Annual Meeting held March 25 to 29, 2022, in Boston, Massachusetts.
Zoe Diana Draelos, MD, FAAD, explains the method of using the color wheel to guide your patients nutrition to help skin, nails, and more.
Master the dialogue about food and skin, hair and nail health.
In this video interview, we sit down with both Jennifer Lin Hsiao, MD, FAAD, and Scott Worswick, MD, FAAD, to talk in detail about their presentation, "Hidradenitis Suppurativa and Pityriasis Rubra Pilaris: Updates on Treatments for Two Conditions that are Difficult to Manage."
A look at the way that skin may react to COVID-19 and the vaccine for the disease.
In their session, “Translating Evidence into Practice: Atopic Dermatitis Guidelines,” at the current AAD annual meeting, Jonathan I. Silverberg, MD, PhD, MPH, FAAD, Peter A. Lio, MD, FAAD, Andrew Blauvelt, MD, FAAD, and Robert Sidbury, MD, MPH, FAAD, discuss updates in new therapies, clinical pearls, and potential co-morbidities.
In this video interview, Christopher Bunick, MD, PhD dives into the topic of congenital ichthyosis describing his talk on the skin condition at the American Academy of Dermatology 2022 Annual Meeting.
Dermatologists continue to be split on the pros and cons of skin cancer screening, from overdiagnosis to early detection of thin melanomas.
A poster presented at AAD 2022 dives into one of the largest barriers in obtaining gender-affirming neurotoxin and filler treatment for patients—the cost.
The company announced the results from its long-term extension study, highlighting improved efficacy outcomes, quality of life, and tolerability data.
A SOC scientific symposium iPoster posited that using self-learning modules to bridge the gap in skin of color dermatology knowledge could be helpful in a medical education curriculum.
Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.
